2 results about "MAGNOLIA BARK" patented technology

The present application relates to the field of traditional Chinese medicine, and provides a traditional Chinese medicine composition for treating chronic gastritis with cold and heat symptoms, which is prepared from the following traditional Chinese medicines in parts by weight: 20-45 parts of lily, 10-25 parts of Jiang Banxia, 10-25 parts of atractylodes, 10-25 parts of white peony root, 8-20 parts of codonopsis, 8-20 parts of Anemarrhena, 8-20 parts of areca nut, 8-20 parts of magnolia bark, 8-20 parts of jujube, 6-15 parts of scutellaria, 6-15 parts of dried ginger, 6-15 parts of licorice, 6-15 parts of fried licorice, 3-12 parts of sandalwood, and 1.5-6 parts of coptis. The present application is based on the theory of traditional Chinese medicine, and can regulate the whole body through multiple targets such as clearing heat and dampness, harmonizing stomach and descending adverse qi, promoting qi circulation and eliminating mass, and nourishing yin and strengthening the body resistance. The present application can promote blood circulation and qi circulation, unblock qi, and improve the overall health of patients with chronic gastritis. Moreover, the present application has few side effects and is suitable for long-term use.

This invention belongs to the field of traditional Chinese medicine (TCM) technology, and particularly relates to a TCM composition, preparation, preparation method, and application. The TCM composition includes areca nut, magnolia bark, cardamom, anemarrhena rhizome, white peony root, scutellaria root, licorice root, honeysuckle flower, forsythia fruit, malt, hawthorn fruit, medicated leaven, and tangerine peel. Experimental results show that after administration of this TCM composition, the IL-10 content in the bronchoalveolar lavage fluid of mice significantly increased; the contents of IL-1β, TNF-α, and IL-6 significantly decreased. This indicates that the TCM composition can reduce lung tissue inflammatory damage by inhibiting the release of pro-inflammatory cytokines IL-1β, TNF-α, and IL-6, and promoting the content of the anti-inflammatory cytokine IL-10. This indicates that the TCM composition has a good therapeutic effect in antiviral inflammatory responses. The drug for antiviral inflammatory responses is a traditional Chinese medicine preparation, safe to use, and the preparation method is simple, rapid, efficient, and easy to operate. The prepared mixtures, granules, pills, tablets, capsules, etc., are easy to carry and convenient to take.